Nuwellis, Inc. financial data

Symbol
NUWE on Nasdaq, NUWEW on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
12988 Valley View Road, Eden Prairie, Minnesota
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CHF Solutions, Inc. (to 4/16/2021), Sunshine Heart, Inc. (to 5/23/2017)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 192 % -55.2%
Quick Ratio 58.1 % -14.7%
Debt-to-equity 593 % +1065%
Return On Equity -1.72K % -1183%
Return On Assets -246 % -177%
Operating Margin -153 % +34.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.38M shares -25.8%
Common Stock, Shares, Outstanding 516K shares -72.3%
Entity Public Float 5M USD -19.4%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 410K shares +980%
Weighted Average Number of Shares Outstanding, Diluted 410K shares +980%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.01M USD +8.54%
Research and Development Expense 4.38M USD -13.5%
Operating Income (Loss) -13.8M USD +28.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.9M USD -22.5%
Income Tax Expense (Benefit) 8K USD -11.1%
Net Income (Loss) Attributable to Parent -20.9M USD -22.5%
Earnings Per Share, Basic 102 USD/shares +85.2%
Earnings Per Share, Diluted 102 USD/shares +85.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.02M USD -88.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.29M USD +9.86%
Inventory, Net 1.97M USD -28%
Other Assets, Current 544K USD -42.3%
Assets, Current 4.83M USD -64.9%
Property, Plant and Equipment, Net 630K USD -28%
Operating Lease, Right-of-Use Asset 613K USD -24.3%
Other Assets, Noncurrent 120K USD 0%
Assets 6.19M USD -60.2%
Accounts Payable, Current 1.56M USD -15.7%
Employee-related Liabilities, Current 706K USD -42.8%
Liabilities, Current 4.02M USD +4.99%
Operating Lease, Liability, Noncurrent 428K USD -34.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 13M USD +191%
Retained Earnings (Accumulated Deficit) -300M USD -7.51%
Stockholders' Equity Attributable to Parent -6.84M USD -162%
Liabilities and Equity 6.19M USD -60.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.86M USD +53.1%
Net Cash Provided by (Used in) Financing Activities 500K USD
Net Cash Provided by (Used in) Investing Activities -29K USD +70.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 516K shares -72.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.4M USD +61.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.02M USD -88.5%
Deferred Tax Assets, Valuation Allowance 52.3M USD +7.81%
Deferred Tax Assets, Gross 52.3M USD +7.81%
Operating Lease, Liability 760K USD -20.5%
Payments to Acquire Property, Plant, and Equipment 29K USD +123%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid 862K USD -22.4%
Property, Plant and Equipment, Gross 4.21M USD +1.42%
Operating Lease, Liability, Current 226K USD +9.71%
Lessee, Operating Lease, Liability, to be Paid, Year Two 264K USD +2.72%
Lessee, Operating Lease, Liability, to be Paid, Year One 257K USD +3.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 102K USD -34.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 272K USD +3.03%
Deferred Tax Assets, Operating Loss Carryforwards 48.8M USD +7.52%
Preferred Stock, Shares Authorized 39.4M shares -1.55%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 69K USD -74.6%
Additional Paid in Capital 293M USD +1.05%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 86K USD -18.1%
Share-based Payment Arrangement, Expense 565K USD -26%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%